# ELDN (Eledon Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Eledon Pharmaceuticals, Inc. reported $106.6M in total assets and a net loss of $85.03M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ELDN
- Markdown: https://convexityos.com/fundamentals/ELDN.md
- SEC CIK: 0001404281
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:43 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001404281&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -- | Operating profit |
| Net Income | FY 2025 | -$85.03M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.74 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $69.67M | Total debt: $376K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Research & Development | $66.27M | $51.96M | $30.31M | $27.08M | $23.73M | $6.13M | $8.13M | $6.82M | $2.02M | $3.19M |
| Total Operating Expenses | $83.25M | $70.58M | $43.00M | $88.43M | $36.87M | $18.46M | $16.05M | $14.06M | $13.12M | $5.13M |
| **Operating Income** | -- | -- | -$43.00M | -$88.43M | -$36.87M | -$18.46M | -$16.05M | -$14.06M | -$13.12M | -$5.13M |
| **EBITDA** | -- | -- | -- | -- | -- | -$18.46M | -$16.04M | -$14.05M | -$13.10M | -$5.09M |
| Income Before Tax | -$45.58M | -$35.75M | -$116.5M | -$87.97M | -$36.86M | -$23.21M | -$16.01M | -$14.06M | -$13.12M | -$5.66M |
| Income Tax Expense | $35K | $431K | $0 | $0 | -$2.35M | -$404K | -- | -- | -- | $0 |
| **Net Income** | -$45.62M | -$36.18M | -$116.5M | -$87.97M | -$34.51M | -$22.81M | -$16.01M | -$14.06M | -$13.12M | -$5.66M |
| Basic EPS | -$0.52 | -$0.66 | -$4.73 | -$6.16 | -$2.33 | -$15.72 | -$24.42 | -$28.06 | -$372.34 | -$398.24 |
| **Diluted EPS** | -$0.52 | -$0.66 | -$4.73 | -$6.16 | -$2.33 | -$15.72 | -$24.42 | -$28.06 | -$372.34 | -$398.24 |
| Basic Shares Outstanding | 81.8M | 48.5M | 24.6M | 14.3M | 14.8M | 1.5M | 655.5K | 500.7K | 28.9K | 2.4K |
| Diluted Shares Outstanding | 81.8M | 48.5M | 24.6M | 14.3M | 14.8M | 1.5M | 655.5K | 500.7K | 28.9K | 2.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $17.76M | $18.23M | $17.20M | $17.49M | $14.97M | $20.28M | $13.53M | $17.93M |
| Total Operating Expenses | $21.67M | $22.87M | $21.18M | $21.48M | $19.07M | $24.73M | $17.96M | $24.70M |
| **Operating Income** | -$21.67M | -$22.87M | -$21.18M | -- | -$19.07M | -$24.73M | -$17.96M | -- |
| **Net Income** | -$3.93M | -$31.63M | -$39.02M | -$10.45M | -$17.46M | -$11.22M | -$6.50M | -$44.62M |
| Basic EPS | -$0.03 | -$0.27 | -$0.33 | -- | -$0.21 | -$0.13 | -$0.08 | -- |
| **Diluted EPS** | -$0.03 | -$0.27 | -$0.33 | -- | -$0.21 | -$0.13 | -$0.08 | -- |
| Basic Shares Outstanding | 114.7M | 113.6M | 112.4M | -- | 77.2M | 77.2M | 77.1M | -- |
| Diluted Shares Outstanding | 114.7M | 113.6M | 112.4M | -- | 77.2M | 77.2M | 77.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $22.81M | $20.55M | $4.61M | $56.41M | $84.83M | $114.2M | $8.79M | $12.97M | $17.23M | $1.10M |
| Short-Term Investments | $110.5M | $119.6M | $46.49M | $0 | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $133.3M | $140.2M | $51.10M | $56.41M | $84.83M | $114.2M | $8.79M | $12.97M | $17.23M | $1.10M |
| Other Current Assets | $11K | $104K | $90K | $28K | $34K | $38K | $54K | $36K | $18K | $33K |
| **Total Current Assets** | $135.7M | $143.7M | $56.13M | $59.52M | $88.35M | $115.6M | $9.97M | $14.28M | $19.00M | $1.15M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $5.0K | $14K | $25K | $31K |
| Goodwill | -- | -- | $0 | $0 | $48.65M | $48.65M | -- | $1.87M | $1.87M | -- |
| Other Non-Current Assets | $322K | $363K | $186K | $150K | $400K | $383K | $639K | $869K | -- | $15K |
| **Total Non-Current Assets** | $33.32M | $33.67M | $32.94M | $33.27M | $82.20M | $81.56M | $960K | $2.75M | $1.89M | $46K |
| **Total Assets** | $169.0M | $177.4M | $89.07M | $92.79M | $170.5M | $197.2M | $10.93M | $17.03M | $20.89M | $1.20M |
| Accounts Payable | $3.63M | $5.83M | $967K | $2.20M | $1.81M | $1.37M | $329K | $689K | $418K | $338K |
| **Total Current Liabilities** | $18.34M | $11.58M | $3.90M | $6.47M | $4.40M | $2.48M | $1.32M | $2.53M | -- | $3.90M |
| **Total Non-Current Liabilities** | $13.89M | $47.69M | $77.96M | $2.13M | $2.15M | $4.11M | $144K | $0 | -- | $84K |
| **Total Liabilities** | $32.23M | $59.27M | $81.86M | $8.61M | $6.55M | $6.59M | $1.47M | $2.53M | $1.44M | $3.90M |
| **Total Debt (incl. Leases)** | $641K | $954K | $383K | $746K | $769K | $144K | $324K | -- | -- | -- |
| Common Stock | $75K | $60K | $24K | $14K | $14K | $15K | $1.0K | $9.0K | $7.0K | $1.0K |
| Retained Earnings | -$401.2M | -$355.6M | -$319.4M | -$202.9M | -$114.9M | -$80.39M | -$57.58M | -$41.57M | -$27.51M | -$14.39M |
| Accumulated Other Comp. Income | $24K | $26K | -- | -- | -- | -- | -- | -- | -- | -$1.0K |
| **Total Stockholders' Equity** | $81.08M | $62.45M | -$48.49M | $84.18M | $164.0M | $190.6M | $9.46M | $14.49M | $19.45M | -$2.70M |
| Total Equity | $81.08M | $62.45M | -$48.49M | $84.18M | $164.0M | $190.6M | $9.46M | $14.49M | $19.45M | -$2.70M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.88M | $6.80M | $6.15M | $22.81M | $3.67M | $5.74M | $8.50M | $20.55M |
| Short-Term Investments | $62.79M | $81.95M | $104.9M | $110.5M | $89.73M | $101.8M | $116.4M | $119.6M |
| **Cash & Short-Term Investments** | $69.70M | $88.80M | $111.1M | $133.3M | $93.40M | $107.6M | $124.9M | $140.2M |
| Other Current Assets | $497K | $382K | $9.0K | $11K | $14K | $10K | $55K | $104K |
| **Total Current Assets** | $73.71M | $93.09M | $113.6M | $135.7M | $96.30M | $111.4M | $127.7M | $143.7M |
| Other Non-Current Assets | $185K | $172K | $177K | $322K | $476K | $346K | $354K | $363K |
| **Total Non-Current Assets** | $32.93M | $33.00M | $33.09M | $33.32M | $33.56M | $33.51M | $33.59M | $33.67M |
| **Total Assets** | $106.6M | $126.1M | $146.7M | $169.0M | $129.9M | $144.9M | $161.3M | $177.4M |
| Accounts Payable | $2.84M | $3.21M | $6.58M | $3.63M | $4.63M | $5.83M | $2.90M | $5.83M |
| **Total Current Liabilities** | $11.70M | $11.79M | $13.46M | $18.34M | $14.30M | $13.72M | $9.19M | $11.58M |
| **Total Non-Current Liabilities** | $25.12M | $42.27M | $32.75M | $13.89M | $24.51M | $25.16M | $37.54M | $47.69M |
| **Total Liabilities** | $36.83M | $54.06M | $46.21M | $32.23M | $38.80M | $38.88M | $46.73M | $59.27M |
| **Total Debt (incl. Leases)** | $376K | $467K | $555K | $641K | $722K | $803K | $880K | $954K |
| Common Stock | $82K | $81K | $76K | $75K | $60K | $60K | $60K | $60K |
| Retained Earnings | -$475.8M | -$471.9M | -$440.2M | -$401.2M | -$390.8M | -$373.3M | -$362.1M | -$355.6M |
| Accumulated Other Comp. Income | -$126K | -$114K | -$72K | $24K | $9.0K | -$48K | -$18K | $26K |
| **Total Stockholders' Equity** | $30.80M | $33.01M | $44.76M | $81.08M | $35.36M | $50.33M | $58.89M | $62.45M |
| Total Equity | $30.80M | $33.01M | $44.76M | $81.08M | $35.36M | $50.33M | $58.89M | $62.45M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$45.62M | -$36.18M | -$116.5M | -$87.97M | -$34.51M | -$22.81M | -$16.01M | -$14.06M | -$13.12M | -$5.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | $5.0K | $9.0K | $11K | $22K | $35K |
| Stock-Based Compensation | $10.45M | $13.12M | $6.54M | $8.15M | $7.90M | $3.17M | $1.31M | $1.54M | $579K | $171K |
| Change in Payables | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$778K |
| **Operating Cash Flow** | -$62.34M | -$47.27M | -$39.53M | -$28.42M | -$28.91M | -$15.21M | -$13.86M | -$11.89M | -$14.94M | -$4.92M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$9.0K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$4.93M |
| Purchases of Investments | -$161.1M | -$156.1M | -$78.29M | -- | -- | -- | -- | -- | -- | -$500K |
| **Investing Cash Flow** | $10.79M | -$70.31M | -$45.29M | -- | -- | $11.04M | -- | -- | $23.26M | $1.0K |
| Common Stock Issued | -- | -- | -- | -- | -- | $9.00M | $9.68M | $7.49M | $4.75M | -- |
| **Financing Cash Flow** | $53.81M | $133.5M | $33.02M | -- | -$449K | $109.6M | $9.68M | $7.56M | $7.87M | $2.93M |
| **Net Change in Cash** | $2.26M | $15.94M | -$51.80M | -$28.42M | -$29.36M | $105.4M | -$4.18M | -$4.33M | $16.19M | -$1.99M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.93M | -$31.63M | -$39.02M | -$10.45M | -$17.46M | -$11.22M | -$6.50M | -$44.62M |
| Stock-Based Compensation | $1.92M | $3.15M | $2.20M | $2.46M | $2.43M | $2.69M | $2.86M | $6.58M |
| **Operating Cash Flow** | -$18.98M | -$22.68M | -$22.61M | -$14.09M | -$14.48M | -$17.71M | -$16.06M | -$18.99M |
| Purchases of Investments | -$9.37M | -$16.26M | -$43.12M | -$69.22M | -$32.66M | -$27.40M | -$31.85M | -$72.78M |
| **Investing Cash Flow** | $19.33M | $23.24M | $5.96M | -$20.46M | $12.40M | $14.96M | $3.89M | -$47.38M |
| **Financing Cash Flow** | -- | -- | -- | $53.69M | $0 | $0 | $115K | $80.17M |
| **Net Change in Cash** | $79K | $651K | -$16.66M | $19.14M | -$2.07M | -$2.75M | -$12.05M | $13.80M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -56.3% | -57.9% | -- | -104.5% | -21.0% | -12.0% | -169.2% | -97.1% | -67.4% | -- |
| Return on Assets (ROA) | -27.0% | -20.4% | -130.8% | -94.8% | -20.2% | -11.6% | -146.5% | -82.6% | -62.8% | -472.8% |
| Current Ratio | 7.40x | 12.42x | 14.41x | 9.19x | 20.07x | 46.57x | 7.54x | 5.63x | -- | 0.30x |
| Quick Ratio | 7.27x | 12.11x | 13.12x | 8.71x | 19.28x | 45.99x | 6.65x | 5.12x | -- | 0.28x |
| Debt to Equity | 0.01x | 0.02x | -- | 0.01x | 0.00x | 0.00x | 0.03x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -276.1% | -298.6% | -174.6% | -56.3% | -225.6% | 29.1% | -32.3% | -57.9% |
| Return on Assets (ROA) | -79.7% | -78.2% | -53.3% | -27.0% | -61.4% | 10.1% | -11.8% | -20.4% |
| Current Ratio | 6.30x | 7.90x | 8.44x | 7.40x | 6.74x | 8.12x | 13.91x | 12.42x |
| Quick Ratio | 5.96x | 7.53x | 8.26x | 7.27x | 6.53x | 7.84x | 13.60x | 12.11x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.01x | 0.02x |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -122.7% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -120.0% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
